Literature DB >> 29558245

Role of Psychosocial Factors on Communicative Participation among Survivors of Head and Neck Cancer.

Tanya Eadie1,2, Lauren Faust1, Susan Bolt1, Mara Kapsner-Smith1, Rebecca Hunting Pompon1,3, Carolyn Baylor4, Neal Futran2, Eduardo Méndez2,5.   

Abstract

Objective The purpose of this study was to examine the unique contribution of psychosocial factors, including perceived social support, depression, and resilience to communicative participation, among adult survivors of head and neck cancer (HNC). Study Design Cross-sectional. Setting University-based laboratory and speech clinic. Subjects and Methods Adult survivors of HNC who were at least 2 years posttreatment for HNC completed patient-reported outcome measures, including those related to communicative participation and psychosocial function. Multiple linear regression analysis was conducted to predict communicative participation. Self-rated speech severity, cognitive function, laryngectomy status, and time since diagnosis were entered first as a block of variables (block 1), and psychosocial factors were entered second (block 2). Results Eighty-eight adults who were on average 12.2 years post-HNC diagnosis participated. The final regression model predicted 58.2% of the variance in communicative participation (full model R2 = 0.58, P < .001). Self-rated speech severity, cognitive function, laryngectomy status, and time since diagnosis together significantly predicted 46.1% of the variance in block 1. Perceived social support, depression, resilience, and interactions significantly and uniquely predicted 12.1% of the additional variance in block 2. Conclusion For clinicians, psychosocial factors such as perceived depression warrant consideration when counseling patients with HNC about communication outcomes and when designing future studies related to rehabilitation.

Entities:  

Keywords:  cancer outcomes; communication disorders; head and neck cancer; perceived depression; psychosocial outcomes

Mesh:

Year:  2018        PMID: 29558245      PMCID: PMC6080254          DOI: 10.1177/0194599818765718

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  26 in total

1.  Quality of life and recurrence concern in survivors of head and neck cancer.

Authors:  B H Campbell; A Marbella; P M Layde
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

2.  Variables Associated With Communicative Participation After Head and Neck Cancer.

Authors:  Susan Bolt; Tanya Eadie; Kathryn Yorkston; Carolyn Baylor; Dagmar Amtmann
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-12-01       Impact factor: 6.223

3.  Assessing head and neck cancer patient outcome domains.

Authors:  L H Karnell; G F Funk; H T Hoffman
Journal:  Head Neck       Date:  2000-01       Impact factor: 3.147

4.  A blessing and a curse: head and neck cancer survivors' experiences.

Authors:  Barbara Swore Fletcher; Marlene Z Cohen; Karen Schumacher; William Lydiatt
Journal:  Cancer Nurs       Date:  2012 Mar-Apr       Impact factor: 2.592

5.  The relationship between communicative participation and postlaryngectomy speech outcomes.

Authors:  Tanya L Eadie; Devon Otero; Steven Cox; Jordan Johnson; Carolyn R Baylor; Kathryn M Yorkston; Philip C Doyle
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

6.  Communicative participation and quality of life in head and neck cancer.

Authors:  Tanya L Eadie; Kristin Lamvik; Carolyn R Baylor; Kathryn M Yorkston; Jiseon Kim; Dagmar Amtmann
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-04       Impact factor: 1.547

7.  Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers.

Authors:  Rebecca L Nund; Anna F Rumbach; Bridget C Debattista; Martha N T Goodrow; Kori A Johnson; Laura N Tupling; Nerina A Scarinci; Bena Cartmill; Elizabeth C Ward; Sandro V Porceddu
Journal:  Int J Speech Lang Pathol       Date:  2015-03-13       Impact factor: 2.484

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  The Communicative Participation Item Bank (CPIB): item bank calibration and development of a disorder-generic short form.

Authors:  Carolyn Baylor; Kathryn Yorkston; Tanya Eadie; Jiseon Kim; Hyewon Chung; Dagmar Amtmann
Journal:  J Speech Lang Hear Res       Date:  2013-07-01       Impact factor: 2.297

10.  Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Authors:  D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

View more
  4 in total

1.  Relationship between perceived social support and patient-reported communication outcomes across communication disorders: a systematic review.

Authors:  Tanya Eadie; Mara Kapsner-Smith; Susan Bolt; Cara Sauder; Kathryn Yorkston; Carolyn Baylor
Journal:  Int J Lang Commun Disord       Date:  2018-07-24       Impact factor: 3.020

2.  Predicting Communicative Participation in Adults Across Communication Disorders.

Authors:  Jingyu Linna Jin; Carolyn Baylor; Kathryn Yorkston
Journal:  Am J Speech Lang Pathol       Date:  2021-03-03       Impact factor: 2.408

3.  Association Between Communicative Participation and Psychosocial Factors in Patients With Voice Disorders.

Authors:  Viann N Nguyen-Feng; Alexa Asplund; Patricia A Frazier; Stephanie Misono
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-12-23       Impact factor: 6.223

4.  Communicative Participation and Quality of Life in Pretreatment Oral and Oropharyngeal Head and Neck Cancer.

Authors:  Cara Sauder; Mara Kapsner-Smith; Carolyn Baylor; Kathryn Yorkston; Neal Futran; Tanya Eadie
Journal:  Otolaryngol Head Neck Surg       Date:  2020-09-15       Impact factor: 3.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.